Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

McGill University

$146,934.00

Effects of cell culture plastics on dendritic cells activated using Immunyr(TM)_x000d_ _x000d_

EF 2020-21

Résumé
Cancer immunotherapy has become an increasingly important therapeutic approach in oncology. It is defined as a means to activate a patient's own immune system to recognize and respond to a developing tumor. Our goal is to develop dendritic cell-based cancer vaccines. DCs are the "gatekeepers" of our immune system, and they can have the capacity to activate other immune cells to attack cancers. Kanyr Pharma has developed a technology called Immunyr(TM) that can improve the function of the dendritic cells in culture prior to reinjection into the patients. Kanyr Pharma currently produces these dendritic cells in plastic containers that are not completely closed. Liquids are introduced into the containers manually through caps and lids. For clinical production of the dendritic cells, it would be safer to culture the cells in closed plastic vessels such as bags filled through tubing. The use of closed cell culture vessels would help move dendritic cell based cancer vaccines into most university hospitals, reduce cost assure higher quality of the autologous dendritic cells produced for each patient. The main objective of this project is to study the effect of the transition to closed plastic vessels and different plastic materials on the function of dendritic cells obtained in the presence of Immunyr(TM) compounds. _x000d_L'immunothérapie pour traiter le cancer est une approche de plus en plus prépondérante en oncologie. Cette approche consiste à activer le système immunitaire du patient afin qu'il reconnaisse et réponde à la tumeur émergente. Le but de ce projet est de
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
533984-2018
Name nom
Hoesli, Corinne
Department département
Chemical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2018
Award amount
146934
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:2 - 2
Partie
1
Nb partie
2
Application title
Effects of cell culture plastics on dendritic cells activated using Immunyr(TM)_x000d_ _x000d_
Keyword
NSERC
Application summary
Cancer immunotherapy has become an increasingly important therapeutic approach in oncology. It is defined as a means to activate a patient's own immune system to recognize and respond to a developing tumor. Our goal is to develop dendritic cell-based cancer vaccines. DCs are the "gatekeepers" of our immune system, and they can have the capacity to activate other immune cells to attack cancers. Kanyr Pharma has developed a technology called Immunyr(TM) that can improve the function of the dendritic cells in culture prior to reinjection into the patients. Kanyr Pharma currently produces these dendritic cells in plastic containers that are not completely closed. Liquids are introduced into the containers manually through caps and lids. For clinical production of the dendritic cells, it would be safer to culture the cells in closed plastic vessels such as bags filled through tubing. The use of closed cell culture vessels would help move dendritic cell based cancer vaccines into most university hospitals, reduce cost assure higher quality of the autologous dendritic cells produced for each patient. The main objective of this project is to study the effect of the transition to closed plastic vessels and different plastic materials on the function of dendritic cells obtained in the presence of Immunyr(TM) compounds. _x000d_L'immunothérapie pour traiter le cancer est une approche de plus en plus prépondérante en oncologie. Cette approche consiste à activer le système immunitaire du patient afin qu'il reconnaisse et réponde à la tumeur émergente. Le but de ce projet est de